European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Quality assurance in pathology in colorectal cancer screening and diagnosis

Endoscopy

Volumn 44, Issue SUPPL3, 2012, Pages

  Quirke, P ^a   Risio, M ^b   Lambert, R ^c   Von Karsa, L ^c   Vieth, M ^d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CANDIOLO CANCER INSTITUTE   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

classification; colorectal neoplasms; histopathology; mass screening; multidisciplinary evidence based guidelines; population based programmes; precursor lesions

Indexed keywords

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CASE CONTROL STUDY; CASE STUDY; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COLON POLYP; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; COLORECTAL POLYP; COLORECTAL TUMOR; CRONKHITE CANADA SYNDROME; CYTODIAGNOSIS; CYTOPATHOLOGY; DISSECTION; ENDOSCOPY; EUROPEAN UNION; EVIDENCE BASED PRACTICE; EXCISION; HEALTH CARE QUALITY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYPERPLASTIC POLYP; INFLAMMATORY POLYP; INFORMATION PROCESSING; INTESTINE EPITHELIUM; INTESTINE METAPLASIA; LABORATORY TEST; LYMPH VESSEL; MEDICAL TERMINOLOGY; MIXED LESION; MIXED POLYP; NEUROENDOCRINE TUMOR; OCCULT BLOOD; PATIENT MONITORING; PEUTZ JEGHERS SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM ADENOMA; RETROSPECTIVE STUDY; REVIEW; SAMPLE SIZE; SERRATED POLYPOSIS; SESSILE SERRATED LESION; SESSILE SERRATED POLYP; SIGMOIDOSCOPY; SYSTEMATIC REVIEW; TISSUE FIXATION; TRADITIONAL SERRATED ADENOMA; TUMOR BIOPSY; TUMOR CELL; TUMOR VOLUME;

ADENOCARCINOMA; ADENOMA; ADENOMATOUS POLYPS; COLONIC POLYPS; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; EUROPEAN UNION; HUMANS; INTESTINAL MUCOSA; MASS SCREENING; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; QUALITY ASSURANCE, HEALTH CARE; SPECIMEN HANDLING;

EID: 84866551409     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0032-1309797     Document Type: Review

References (85)

1. Atkin W., Valori R., Kuipers E. J. et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Colonoscopic surveillance following adenoma removal. Endoscopy: 2012; 44 SE151 SE163
2. Austoker J., Giordano L., Hewitson P. et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Communication. Endoscopy: 2012; 44 SE164 SE185
3. Beattie G. C., McAdam T. K., Elliott S. et al. Improvement in quality of colorectal cancer pathology reporting with a standardized proforma - a comparative study. Colorectal Dis: 2003; 5 558 562
4. Blumberg D., Paty P. B., Guillem J. G. et al. All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum: 1999; 42 881 885
5. Branston L. K., Greening S., Newcombe R. G. et al. The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur J Cancer: 2002; 38 764 772
6. Burt R., Jass J. Hyperplastic Polyposis. World Health Organisation classification of tumours: Pathology and genetics of tumours of the digestive system. Lyon IARC Press: 2000; 135 136
7. Cooper H. S., Deppisch L. M., Gourley W. K. et al. Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology: 1995; 108 1657 1665
8. Cooper H. S., Deppisch L. M., Kahn E. I. et al. Pathology of the malignant colorectal polyp. Hum Pathol: 1998; 29 15 26
9. Council of the European Union Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC). Off J Eur Union: 2003; 34 38
10. Coverlizza S., Risio M., Ferrari A. et al. Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential. Cancer: 1989; 64 1937 1947
11. Cross S. S., Feeley K. M., Angel C. A. The effect of four interventions on the informational content of histopathology reports of resected colorectal carcinomas. J Clin Pathol: 1998; 51 481 482
12. DAP-TM-30 Leitfaden zur Interpretation der Anforderungen der DIN EN ISO/IEC 17020: 2004 und technische Kriterien fuer deren Anwendung zur Akkreditierung in der Pathologie/Neuropathologie. 2007; http://www.dap.de/95doc/ DAP-TM-30.pdf Accessed 11/2/2012
13. Deinlein P., Reulbach U., Stolte M. et al. Risk factors for lymphatic metastasis from pT1 colorectal adenocarcinoma. Pathologe: 2003; 24 387 393
14. Dixon M. F. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut: 2002; 51 130 131
15. EC Working Group on Breast Screening Pathology Quality assurance guidelines for pathology. Open biopsy and resection specimens. In: Perry N., Broeders M., de Wolf C. et al. (eds.) European guidelines for quality assurance in breast cancer screening and diagnosis. 4th edition Luxembourg Office for Official Publications of the European Communities: 2006
16. Eon Y., Le Douy J. Y., Lamer B. et al. Quality and completeness of histopathology reports of rectal cancer resections. Results of an audit in Brittany. Gastroenterol Clin Biol: 2006; 30 235 240
17. Fenger C., Bak M., Kronborg O. et al. Observer reproducibility in grading dysplasia in colorectal adenomas: comparison between two different grading systems. J Clin Pathol: 1990; 43 320 324
18. Ferlay J., Shin H. R., Bray F. et al. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. [Internet] Lyon, France International Agency for Research on Cancer: 2010; Available from: http://globocan.iarc.fr Accessed on 05/04/2012
19. Gondal G., Grotmol T., Hofstad B. et al. Biopsy of colorectal polyps is not adequate for grading of neoplasia. Endoscopy: 2005; 37 1193 1197
20. Haggitt R. C., Glotzbach R. E., Soffer E. E. et al. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology: 1985; 89 328 336
21. Halloran S., Launoy G., Zappa M. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Faecal Occult Blood Testing. Endoscopy: 2012; 44 SE65 SE87
22. Hassan C., Zullo A., Risio M. et al. Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis Colon Rectum: 2005; 48 1588 1596
23. Jass J. R., Baker K., Zlobec I. et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a "fusiono" pathway to colorectal cancer. Histopathology: 2006; 49 121 131
24. Jass J. R., O'Brien J., Riddell R. H. et al. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma: Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol: 2008; 129 13 23
25. Jass J. R., Williams C. B., Bussey H. J. et al. Juvenile polyposis - a precancerous condition. Histopathology: 1988; 13 619 630
26. Kikuchi R., Takano M., Takagi K. et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum: 1995; 38 1286 1295
27. Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy: 1993; 25 455 461
28. Kudo S., Lambert R., Allen J. I. et al. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc: 2008; 68 3 47
29. Landsorp-Vogelaar I., von Karsa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis: First edition. Introduction. Endoscopy: 2012; 44 SE15 SE30
30. Longacre T. A., Fenoglio-Preiser C. M. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol: 1990; 14 524 537
31. Malila N., Senore C., Armaroli P. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Organisation. Endoscopy: 2012; 44 SE31 SE48
32. Masaki T., Matsuoka H., Sugiyama M. et al. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J Gastroenterol Hepatol: 2006; 21 1115 1121
33. Minozzi S., Armaroli P., Banzi R. et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis First edition. Appendix 1: Systematic evidence review. 2010; http://bookshop.europa.eu/en/european- guidelines-for-quality-assurance-in-colorectal-cancer-screening-and-diagnosis- pbND3210390/ Accessed 11/2/2012
34. Minozzi S., Armaroli P., Segnan N. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Principles of evidence assessment and methods for reaching recommendations. Endoscopy: 2012; 44 SE9 SE14
35. Moss S., Ancelle-Park R., Brenner H. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Evaluation and interpretation of screening outcomes. Endoscopy: 2012
36. Muto T., Bussey H. J., Morson B. C. Pseudo-carcinomatous invasion in adenomatous polyps of the colon and rectum. J Clin Pathol: 1973; 26 25 31
37. Nascimbeni R., Burgart L. J., Nivatvongs S. et al. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum: 2002; 45 200 206
38. NHS Bowel Cancer Screening Programme Reporting lesions in the NHS Bowel Cancer Screening Programme guidelines from the Bowel Cancer Screening Programme Pathology Group. 2007; http://www.cancerscreening.nhs.uk/bowel/publications/ nhsbcsp01.pdf Accessed 11/2/2012
39. Okuyama T., Oya M., Ishikawa H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum: 2002; 45 628 634
40. Oppong C., Robertson N., Sherwood A. et al. The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Engl: 2002; 84 290
41. Prall F. Tumour budding in colorectal carcinoma. Histopathology: 2007; 50 151 162
42. Quirke P., Cuvelier C., Ensari A. et al. Evidence-based medicine: the time has come to set standards for staging. J Pathol: 2010; 221 357 360
43. Quirke P., Risio M., Lambert R. et al. Quality assurance in pathology in colorectal cancer screening and diagnosis-European recommendations. Virchows Arch: 2011; 458 1 9
44. Quirke P., Williams G. T. Minimum Dataset for Colorectal Cancer Histopathology Reports. London Royal college of Pathologists: 1998
45. Quirke P., Williams G. T., Ectors N. et al. The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol: 2007; 8 651 657
46. Rigby K., Brown S. R., Lakin G. et al. The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Engl: 1999; 81 401 403
47. Risio M., Baccarini P., Casson P. et al. Histopathologic diagnosis in colorectal cancer screening: guidelines. Pathologica: 2006; 98 171 174
48. Risio M., Bussolati G., Senore C. et al. Virtual microscopy for histology quality assurance of screen-detected polyps. J Clin Pathol: 2010; 63 916 920
49. Rocken C., Manke H. Accreditation in pathology. Systematic presentation and documentation of activities in pathology. Pathologe: 2010; 31 268 278
50. Sakuragi M., Togashi K., Konishi F. et al. Predictive factors for lymph node metastasis in T1 stage colorectal carcinomas. Dis Colon Rectum: 2003; 46 1626 1632
51. Schlemper R. J., Kato Y., Stolte M. Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol: 2001; 36 445 456
52. Schlemper R. J., Riddell R. H., Kato Y. et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut: 2000; 47 251 255
53. Schmiegel W., Reinacher-Schick A., Arnold D. et al. Update S3-guideline "colorectal cancero" 2008. Z Gastroenterol: 2008; 46 799 840
54. Schoen R. E., Gerber L. D., Margulies C. The pathologic measurement of polyp size is preferable to the endoscopic estimate. Gastrointest Endosc: 1997; 46 492 496
55. Segnan N., Patnick J., von Karsa L. (eds.) European guidelines for quality assurance in colorectal cancer screening and diagnosis First edition. Luxembourg European Commission, Publications Office of the European Union: 2010
56. SIGN Scottish Intercollegiate Guidelines Network Guidelines for the management of colorectal cancer. 2003; http://www.sign.ac.uk/pdf/sign67.pdf Accessed 11/2/2012
57. Snover D. C., Jass J. R., Fenoglio-Preiser C. et al. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol: 2005; 124 380 391
58. Sobin L. H., Gospodarowicz M. K., Wittekind C. (eds) TNM Classification of Malignant Tumours. 7th edition Wiley-Blackwell: 2009
59. Sobin L. H., Wittekind C. (eds.) TNM Classification of malignant tumours. 6th edition New Jersey John Wiley & Sons: 2002
60. Sobin L. H., Wittekind C. (eds.) TNM classification of malignant tumours. 5th edition New York John Wiley & Sons, Inc: 1997
61. Soetikno R. M., Kaltenbach T., Rouse R. V. et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA: 2008; 299 1027 1035
62. Steele R. JC, Pox C., Kuipers E. J. et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Management of lesions detected in colorectal cancer screening. Endoscopy: 2012; 44 SE140 SE150
63. Steele R. JC, Rey J-F, Lambert R. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Professional requirements and training. Endoscopy: 2012; 44 SE106 SE115
64. Stolte M. The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages. Virchows Arch: 2003; 442 99 106
65. Suzuki N., Price A. B., Talbot I. C. et al. Flat colorectal neoplasms and the impact of the revised Vienna Classification on their reporting: a case-control study in UK and Japanese patients. Scand J Gastroenterol: 2006; 41 812 819
66. The Paris Classification The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc: 2003; 58 3 43
67. Tominaga K., Fujinuma S., Endo T. et al. Efficacy of the revised Vienna Classification for diagnosing colorectal epithelial neoplasias. World J Gastroenterol: 2009; 15 2351 2356
68. Torlakovic E. E., Gomez J. D., Driman D. K. et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol: 2008; 32 21 29
69. Ueno H., Mochizuki H., Hashiguchi Y. et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology: 2004; 127 385 394
70. Valori R., Rey J-F, Atkin W. et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Quality assurance in endoscopy in colorectal screening and diagnosis. Endoscopy: 2012; 44 SE88 SE105
71. Vereniging integrale kankercentra Colon cancer. Nation-wide guideline, Version: 2.0. 2008; http://www.oncoline.nl/richtlijn/doc/index.php?type= save&richtlijn-id=598 Accessed 11/2/2012
72. Vereniging integrale kankercentra Rectal cancer. Nation-wide guideline, Version: 2.0. 2008; http://www.oncoline.nl/richtlijn/doc/index.php?type= save&richtlijn-id=615 Accessed 11/2/2012
73. Vieth M., Quirke P., Lambert R. et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Annex Annotations of colorectal lesions. Endoscopy: 2012; 44 SE131 SE139
74. Volk E. E., Goldblum J. R., Petras R. E. et al. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology: 1995; 109 1801 1807
75. von Karsa L., Anttila A., Ronco G. et al. Cancer Screening in the European Union. Report on the implementation of the Council Recommendation on Cancer Screening - First Report. Luxembourg European Commission: 2008; http://ec.europa.eu/health/archive/ph-determinants/genetics/documents/ cancer-screening.pdf Accessed 11/2/2012
76. von Karsa L., Lignini T. A., Patnick J. et al. The dimensions of the CRC problem. Best Pract Res Clin Gastroenterol: 2010; 24 381 396
77. Wang H. S., Liang W. Y., Lin T. C. et al. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum: 2005; 48 1182 1192
78. Washington M. K., Berlin J., Branton P. et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med: 2009; 133 1539 1551
79. Wei J. T., Miller E. A., Woosley J. T. et al. Quality of colon carcinoma pathology reporting: a process of care study. Cancer: 2004; 100 1262 1267
80. WHO Histological Typing of Intestinal Tumours. In: Jass J. R., Sobin L. H. (eds.) World Health Organisation International Histological Classification of Tumours. 30 Berlin Springer: 1989
81. WHO Pathology and genetics of tumours in the digestive system. Carcinoma of the colon and rectum. In: Hamilton S. R., Aaltonen L. A. (eds.) World Health Organization International Histological Classification of Tumours. Lyon IARC Press: 2000; 105 119
82. Williams G. T., Quirke P., Shepherd N. A. Dataset for colorectal cancer. 2007; 2nd edition http://www.rcpath.org/resources/pdf/G049-ColorectalDataset- Sep07.pdf Accessed 11/2/2012
83. Williams G. T., Quirke P., Shepherd N. A. Dataset for colorectal cancer - Appendix C: Proforma for colorectal cancer resections. 2007; 2nd edition http://www.rcpath.org/resources/worddocs/G049ColorectalDatasetAppendixC-Sep07. doc Accessed 11/2/2012
84. Williams G. T., Quirke P., Shepherd N. A. Dataset for colorectal cancer Appendix D: Proforma for local excision specimens. 2007; 2nd edition http://www.rcpath.org/resources/worddocs/G049ColorectalDatasetAppendixD-Sep07. doc Accessed 11/2/2012
85. Wilson J. M., Jungner Y. G. Principles and practice of mass screening for disease. World Health Organization: 1968; http://whqlibdoc.who.int/php/WHO-PHP- 34.pdf Accessed 11/2/2012